• Congressional Personalized Medicine Caucus Precision Medicine Answers for Kids Today Act/Ending the Diagnostic Odyssey Act Right Drug Dose Now Act FDA Proposed Rulemaking on Laboratory Developed Tests Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community CMS Implementation of Medicare Drug Price Negotiation Program CMS Medicare Administrative Contractors Novitas and FCSO proposed Local Coverage Determination (LCD) related to genetic testing for oncology CMS Inpatient Prospective Payment System (IPPS) reimbursement for low-volume rare disease treatments
• FY 2024 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2024 National Institutes of Health Budget Priorities

Duration: March 21, 2008 to present

General Issues: Health Issues, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Fuel/Gas/Oil, Medicare/Medicaid, Science/Technology

Spending: about $1,345,186 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: House of Representatives, Centers For Medicare and Medicaid Services (CMS), U.S. Senate, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), White House Office, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), House of Representatives, Health & Human Services, Dept of (HHS), Senate